| Colistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosa PJ Bergen, J Li, CR Rayner, RL Nation Antimicrobial agents and chemotherapy 50 (6), 1953-1958, 2006 | 452 | 2006 |
| Pharmacokinetics and pharmacodynamics of ‘old’polymyxins: what is new? PJ Bergen, CB Landersdorfer, J Zhang, M Zhao, HJ Lee, RL Nation, J Li Diagnostic microbiology and infectious disease 74 (3), 213-223, 2012 | 223 | 2012 |
| Pharmacokinetic/Pharmacodynamic Investigation of Colistin against Pseudomonas aeruginosa Using an In Vitro Model PJ Bergen, JB Bulitta, A Forrest, BT Tsuji, J Li, RL Nation Antimicrobial agents and chemotherapy 54 (9), 3783-3789, 2010 | 209 | 2010 |
| Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet? TB Tran, T Velkov, RL Nation, A Forrest, BT Tsuji, PJ Bergen, J Li International journal of antimicrobial agents 48 (6), 592-597, 2016 | 178 | 2016 |
| Antimicrobial peptides: an update on classifications and databases A Bin Hafeez, X Jiang, PJ Bergen, Y Zhu International journal of molecular sciences 22 (21), 11691, 2021 | 170 | 2021 |
| Comparison of once-, twice-and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro … PJ Bergen, J Li, RL Nation, JD Turnidge, K Coulthard, RW Milne Journal of antimicrobial chemotherapy 61 (3), 636-642, 2008 | 162 | 2008 |
| Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at … PJ Bergen, A Forrest, JB Bulitta, BT Tsuji, HE Sidjabat, DL Paterson, J Li, ... Antimicrobial agents and chemotherapy 55 (11), 5134-5142, 2011 | 148 | 2011 |
| ‘Old’antibiotics for emerging multidrug-resistant bacteria PJ Bergen, CB Landersdorfer, HJ Lee, J Li, RL Nation Current opinion in infectious diseases 25 (6), 626-633, 2012 | 147 | 2012 |
| Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic model PJ Bergen, BT Tsuji, JB Bulitta, A Forrest, J Jacob, HE Sidjabat, ... Antimicrobial agents and chemotherapy 55 (12), 5685-5695, 2011 | 147 | 2011 |
| The combination of colistin and doripenem is synergistic against Klebsiella pneumoniae at multiple inocula and suppresses colistin resistance in an in vitro pharmacokinetic … ZZ Deris, HH Yu, K Davis, RL Soon, J Jacob, CK Ku, A Poudyal, ... Antimicrobial agents and chemotherapy 56 (10), 5103-5112, 2012 | 117 | 2012 |
| Dosing of colistin—back to basic PK/PD PJ Bergen, J Li, RL Nation Current opinion in pharmacology 11 (5), 464-469, 2011 | 115 | 2011 |
| Synergistic Activity of Colistin and Rifampin Combination against Multidrug-Resistant Acinetobacter baumannii in an In Vitro Pharmacokinetic/Pharmacodynamic … HJ Lee, PJ Bergen, JB Bulitta, B Tsuji, A Forrest, RL Nation, J Li Antimicrobial agents and chemotherapy 57 (8), 3738-3745, 2013 | 112 | 2013 |
| Synergistic killing of NDM-producing MDR Klebsiella pneumoniae by two ‘old’ antibiotics—polymyxin B and chloramphenicol N Abdul Rahim, SE Cheah, MD Johnson, H Yu, HE Sidjabat, J Boyce, ... Journal of Antimicrobial Chemotherapy 70 (9), 2589-2597, 2015 | 100 | 2015 |
| A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections AA Agyeman, PJ Bergen, GG Rao, RL Nation, CB Landersdorfer International journal of antimicrobial agents 55 (1), 105833, 2020 | 92 | 2020 |
| PK/PD models in antibacterial development T Velkov, PJ Bergen, J Lora-Tamayo, CB Landersdorfer, J Li Current opinion in microbiology 16 (5), 573-579, 2013 | 92 | 2013 |
| In vitro pharmacodynamics of fosfomycin against clinical isolates of Pseudomonas aeruginosa CC Walsh, MP McIntosh, AY Peleg, CM Kirkpatrick, PJ Bergen Journal of Antimicrobial Chemotherapy 70 (11), 3042-3050, 2015 | 91 | 2015 |
| An “unlikely” pair: the antimicrobial synergy of polymyxin B in combination with the cystic fibrosis transmembrane conductance regulator drugs KALYDECO and ORKAMBI EK Schneider, MAK Azad, ML Han, Q Zhou, J Wang, JX Huang, ... ACS infectious diseases 2 (7), 478-488, 2016 | 81 | 2016 |
| Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance NS Ly, JB Bulitta, GG Rao, CB Landersdorfer, PN Holden, A Forrest, ... Journal of antimicrobial chemotherapy 70 (5), 1434-1442, 2015 | 78 | 2015 |
| Polymyxin combinations: pharmacokinetics and pharmacodynamics for rationale use PJ Bergen, ZP Bulman, S Saju, JB Bulitta, C Landersdorfer, A Forrest, J Li, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35 (1 …, 2015 | 74 | 2015 |
| Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm … J Lora-Tamayo, O Murillo, PJ Bergen, RL Nation, A Poudyal, X Luo, ... Journal of antimicrobial chemotherapy 69 (9), 2434-2442, 2014 | 73 | 2014 |
